About: Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Hellemans R., Hazzan M., Durand D., Mourad Georges, Lang P., Kessler M., CHARPENTIER B., Touchard G., Berthoux F., Merville P., Ouali N., Squifflet J.P., Bayle F., Wissing K.M., Noel C., Abramowicz D.. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.. American Journal of Transplantation, Wiley, 2015, 15 (7), pp.1923-32. ⟨10.1111/ajt.13191⟩
  • Hazzan M., Durand D., Mourad Georges, Lang P., Kessler M., CHARPENTIER B., Touchard G., Berthoux F., Merville P., Ouali N., Bayle F., Noel C.. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.. American Journal of Transplantation, Wiley, 2015, 15 (7), pp.1923-32. ⟨10.1111/ajt.13191⟩
Title
  • Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.
dc:date
  • 2015
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software